Cantebury IV Line

PERIPHERAL INTRAVENOUS CANNULATION
SELF LEARNING PACKAGE
First Edition
2010
Updated: September 2013
Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 1

Author: Elizabeth Culverwell
Review by:
Dr Heather Byrne PDU Nurse Manager

Dr Simon Burrows – Anaesthetic Consultant
Kerry Davis – IV NE
Tina Hewitt - ME
Sharron Ellis –CNS Haematology day Ward
Leona Robertson – NE Emergency Department
Acknowledgements:
CDHB IV Cannulation Review Group.
Sharron Ellis CNS Haematology Day Ward, Wendy Jar CNS BMTU & Sarah
Ellery CNS Oncology Ward 27 for contributing the extravasation tool.
Hutt Valley District Health Board
B-Braun
3M

CONTENTS
Introduction ...................................................................................................... 5
Competence .................................................................................................... 5
Learning Outcomes.......................................................................................... 6
Anatomy & Physiology ..................................................................................... 7

The Skin ....................................................................................................... 7
Vein Anatomy & Physiology ......................................................................... 8
Differences between Arteries & Veins ...................................................... 9
Vein Location & Characteristics.................................................................... 9
Veins of the Hand ................................................................................... 10
Veins of the Forearm .............................................................................. 11
Infection Control ............................................................................................. 13

Risks of Infection ........................................................................................ 13
Sources of Infection ................................................................................ 13
Blood-Borne Pathogens .......................................................................... 14
Prevention of Infection ................................................................................ 15
Aseptic Technique .................................................................................. 15
Antisepsis ............................................................................................... 15
Occlusive Dressing ................................................................................. 16
Site Care ................................................................................................. 16
Phlebitis ...................................................................................................... 17
IV Solutions & Medications ..................................................................... 17
Assessment ............................................................................................ 18
Phlebitis Scale ........................................................................................ 19
Management ........................................................................................... 19
Removal ..................................................................................................... 20
Sharps Safety ............................................................................................. 20
Needle Stick First Aid ............................................................................. 20
Preparation .................................................................................................... 21
Assessment ................................................................................................ 21
Teaching & Consent ................................................................................... 22
Vein Selection ............................................................................................ 23
Selection of Suitable a Vein .................................................................... 23
Selection of Suitable Site ........................................................................ 23
Cannula Selection ...................................................................................... 24
Guide to INTROCAN Safety IV Cannula ................................................. 24
Equipment .................................................................................................. 25
Parts of the Cannula ............................................................................... 25

Insertion Procedure........................................................................................ 26
Preparing the Patient...............................................................................26
Checking the Cannula ............................................................................ 26
Applying the Tourniquet .......................................................................... 26
Preparing the Site ................................................................................... 27
Encouraging Vein Dilation....................................................................... 27
Holding the Device .................................................................................. 27
Immobilising the Vein.............................................................................. 28
Approaching the Vein ............................................................................. 28
Inserting the Cannula .............................................................................. 29
Advancing the Cannula ........................................................................... 29
Remove the Stylet .................................................................................. 30
Attach Extension Set .............................................................................. 30
Securement & Dressings ........................................................................ 31
Documentation ....................................................................................... 31
ID the IV ......................................................................................................... 32
Trouble Shooting............................................................................................ 33
Potential Complications ................................................................................. 35
Additional Information .................................................................................... 37

Infiltration.................................................................................................37
Extravasation...........................................................................................37
Management of Extravasation.................................................................37
Extravasation Assessment Tool..............................................................38
Follow-up Guidelines...............................................................................38
Information for Midwives and Emergency Nurses 39
Taking blood samples from a cannula 40
Cannulation of Renal Patients 41
References ............................................................................................... 41-43

Additional information…………………………………………………………43

Introduction
Intravenous (IV) therapy is commonplace in acute care settings, with an
estimated 50-70% of patients having some form of IV access device inserted
as part of their treatment (Wilkinson, 1996). Yet it is not without risk.
Complications range from mild local irritation to blood stream infections
associated with significant mortality and morbidity (Lundgren & Wahren,
1999). It is imperative that clinicians involved in the care of IV access devices,
are competent to do so, because the level of skill is critical in reducing and
preventing complications (Robert, et al., 2000).
With increased scope of practice comes increased professional accountability

established through:
1) Demonstrating a level of practice and professional accountability,
appropriate to extending of skills
2) Having sound knowledge of the normal patient response to cannulation
3) Possessing the necessary interpersonal skills for accurate assessment
and treatment negotiation
4) Performing accurate assessment through identifying patient-specific
indications, contraindications and associated risks
5) Acquiring and maintaining competence in the technical skills necessary to
perform IV cannulation
6) Utilising critical thinking skills and evidence based practice to achieve best
patient outcomes
7) Confidently articulating scope of practice, identifying and acknowledging
limitations and seeking assistance appropriately
Competence
Competence in IV therapy is defined as “performing IV therapy in an exact
and effective manner using the appropriate knowledge of nursing, technical
expertise, and specialized skills” (Dugger, 1997, p293). Ongoing compliance
is monitored via audits.
At Canterbury District Health Board (CDHB), competency in IV cannulation is
achieved through:
1) Completing the on line self learning package and test
2) Returning completed test to Professional Development Unit(PDU)
3) Completing the workshop and lab practicum
4) Completing work place practical assessment with cannulating IV Link
staff, or NE/ME Educator. Four cannulations are required
5) CDHB staff - return completed assessment form to the PDU. For
Partnering Organisations – this is marked by your line manager
6) CDHB staff - on successful completion, name is entered onto competency
Training Data base. For Partnering Organisations your line manager will
retain this information

Pre-Requisites:
1. Complete the Level one IV Therapy competency

2. Complete the venepuncture competency
Self Learning Package

This package is designed as a self-directed learning resource for clinicians
who are routinely required to perform peripheral IV cannulation of adult
patients as part of their practice. The handbook describes the knowledge and
techniques for practice requirements to form a comprehensive manual that
will guide you through the process for attaining cannulation competency.
Learning Outcomes
On completion of the Self Learning package, test and attendance at the
workshop, the nurse will be able to:
Describe relevant anatomy and physiology of peripheral venous
system
Identify Blood borne pathogens
Demonstrate familiarity with equipment components and appropriate
selection to meet the goals of IV therapy
Identify peripheral veins suitable for cannulation
Cannulate peripheral veins safely under simulated conditions
Identify measures to minimize and address difficulties encountered
during cannulation
List complications associated with IV cannulation, prevention and
management strategies and cannula removal
Describe infection control considerations and interventions
Describe the action required in the event of a hollow bore needle stick
injury
Describe the Four Tenets of Sharps Safety Devices
Articulate essential aspects of patient communication
Enrolled Nurses Please Note:

This course is available to Transitioned Enrolled Nurses who have been
recommended by their Line Manager.

Anatomy & Physiology
Seventy five percent of blood volume is contained in the venous system. The
veins, because of their abundance and location, present the most readily
accessible route for cannulation. To initiate IV therapy effectively, a clinical
understanding of the anatomy and physiology of the skin and peripheral
venous system is essential.
Skin Structure
The first barrier to successful cannulation is the skin. It consists of two main
layers:
1) The Epidermis – is the least sensitive layer, largely comprised of dead
squamous cells. In general, the epidermis is thickest on the palms of the
hands and soles of the feet and thinnest on the inner surfaces of the
extremities. But, thickness can vary depending on age and exposure to the
sun or wind. The most important function of the epidermis is to act as the
first line of defence against infection.
2) The Dermis – is the thicker and more sensitive layer, as it is well supplied
with nerves. It contains blood vessels, hair follicles, sweat glands
sebaceous glands, small muscles and nerves. For example, one square
cm contains 4 metres of nerves, 200 nerve endings for pain and a metre of
blood vessels.

Vein Anatomy & Physiology
Knowledge of the basic anatomy and physiology of the vein is essential and will
assist you to become a successful IV cannulator. It will enable you to utilise normal
physiological responses to your advantage, for example, using venous dilation
techniques such as opening and closing the hand, tapping the vein or applying
heat to the area of choice.
The following diagram depicts the three different layers of the vein, also known as
coats or „tunics‟ (hence the Latin tunica).
1) The outermost layer is the tunica externa or adventitia, and is composed of

connective tissue, which supports the vessel.
2) The middle layer, the tunica media is composed of primarily smooth muscle. It
contains nerve fibres that cause veins to contract or relax in response to cold or
heat. This layer also responds to chemical or mechanical stimulation, such as
pain. Pain sensed in the tunica media can elicit vasovagal response (Hadaway,
1999) and should be anticipated in sensitive individuals.
3) The third or inner layer is the tunica intima. This innermost layer is less
muscular and thin, accounting for only about 10% of the vessel diameter. It
consists of three parts. 1) An innermost layer of squamous epithelium, 2) a
basement membrane, overlying some connective tissue and 3) a layer of
elastic fibres, or elastin.
Elastin fibres make the lumen very distensible and one-way valves of
endothelial tissue direct blood flow. This means that cannulae should only be
placed in the direction of blood flow. The valves are usually found near
branches of the vein and may inhibit threading of the cannula into the lumen.
There are approximately 40 venous valves between the hand and axilla.

It is important to understand that any damage or abrasion occurring to the tunica
intima during cannula insertion, the duration of cannula dwell, or during removal,
encourages thrombus formation, caused by cells and platelets adhering to the
roughened vessel wall. Damage to this layer causes phlebitis, thrombophlebitis or
even result in occlusion of the vessel from a thrombus. Your insertion technique
and subsequent management of a cannula can contribute to these complications.
Differences between Arteries & Veins

It is important to be able to distinguish between arteries and veins because the aim
is to perform a venous cannulation NOT arterial. The following table describes the
distinguishing features.
Arteries Veins
More muscle for their diameter, Less muscle therefore tend to

therefore appear more round in look more collapsed in cross-
cross-section section
Have a stress relaxation
phenomena
No valves Have valves
Deep and protected More superficial /often visible
Pulsatile Non-pulsitile
ALERT: While an artery can inadvertently be cannulated, it is uncommon. Having a

good understanding of your venous anatomy and checking for pulsation prior to
cannulation is important. This is discussed under “Potential Complications”.
Vein Location & Characteristics

Superficial veins of the hand and arm include the digital, metacarpal, cephalic,
basilic and median veins. The following two sections 1) Veins of the Hand and 2)
Veins of the Forearm provide details of vein location, characteristics and clinical
considerations that will ensure you develop competent assessment and selection
skills that will positively impact on the quality of care your patient receives.

Veins of the Hand & Wrist
The following list of veins can be identified by the corresponding number in the hand diagram.
Location/ Characteristics Clinical Considerations

1) Dorsal digital veins Last resort
Found along the lateral cannula site, as
portion of the fingers and subject to
thumb mechanical
Veins small & fragile phlebitis.
To be cannulated
only by an expert
clinician
If used, must be
immobilized by a
finger splint
2) Dorsal metacarpal veins Good site to start IV therapy for some patients
Between the metacarpal Can accommodate 24-20g cannula
bones on the back of the
Tip of catheter should not extend over wrist joint
hand
Catheter should lie flat on the back of hand
Superficial veins usually
of good size and easily Hub of catheter should not extend over
visualised knuckles
Should not be used for vesicant medication/
fluids
3) Dorsal venous network Comfortable site for the patient
Formed by the union of Can accommodate 24-20g cannula
metacarpal veins, on the
Angle of the vein may deter choice of site
dorsal aspect of the
forearm Avoid placement over the wrist/ prominent ulna
bone which can cause mechanical phlebitis or
Not always prominent
dislodgement
Should not be used for vesicant medication/
fluids

Veins of the Forearm
The following list of veins can be identified by the corresponding number in the arm diagram.
Location/ Characteristics Clinical Considerations

1) Cephalic Vein Accommodates 22-18g cannula
Runs the entire length of the Excellent choice for cannulation
arm from the wrist to the
Should not be used for patient
shoulder
that require fistula formation
Located above antecubital
Radial nerve runs parallel so
fossa, may be difficult to
avoid wrist area
visualise
2) Median Cubital Vein Usually used to draw blood
Lies in antecubital fossa Veins of choice for trauma or shocked patients
Large vein, easily visualised as they can accommodate a large bore cannula
and accessed 16-14g
Limited use for short peripheral cannula due to
joint articulation, limit to patient mobility and
difficulty of detecting infiltration
Complications at this site mean that veins below
this point are not recommended
3) Accessory Cephalic Vein Easily stabilized
Branches off the cephalic vein Accommodates 22-18g cannula
Located on the top of the Avoid catheter tip placement at joint articulation
forearm
Usually good size
4) Basilic Vein Can accommodate 22-16g cannula
Runs the entire length of the Vein rotates around the arm and requires firm
arm from the wrist to axilla skin tension to stabilize vein.
Depicted in the diagram along Increased success can be achieved by placing
medial aspect of upper forearm the patients arm across their chest and
approaching from the opposite side of the bed
5) Dorsal Basilic Vein If accessing the dorsal basilica have the patient
flex the forearm at the elbow(this will also
enhance venous filling and minimize „rolling‟) and
face the patients feet to work on the exposed
underside of the arm
Alternatively have the arm fully extended and
supinate the arm with palm up
6) Median Vein Accommodates 24-20g cannula

Arises from the palm of the May be difficult to palpate
hand, flows upward in the
Runs in close proximity to the nerve
centre of the underside of the
forearm
Medium size & generally easy
to visualize

Veins of the Forearm

Infection Control
Risks of infection associated with cannulation can be

minimised by adherence to standard precautions and
a strict aseptic technique.
Risks of Infection
Cannulation and IV therapy present risks for infection for several reasons.
1) A device penetrates and bypasses the protective barrier of the patient‟s skin.
2) An in-dwelling device is in situ, providing portal entry for micro-organisms to
enter directly into the patient‟s bloodstream.
3) Immune-suppressed or compromised patients are especially vulnerable to
infection.
4) Inadequate skin antisepsis and hand hygiene.
5) Poor securement technique increases the risk of phlebitis and infection.
6) IV infusions have the potential to become contaminated through manipulation
and/or disconnection and glucose containing fluids provide an excellent media
for bacterial growth.
Sources of Infection
The source of infection may be endogenous (part of the patient‟s own skin flora) or
exogenous (from the surrounding environment or people).
Ports of bacterial entry, in order of significance are:

1) Skin colonization.
2) Hub colonization.
3) Contaminated infusates or transducer domes.
4) Haematogenous seeding of infection from remote sources within the body.
5) Skin colonization from remote sources of infection within the body.
PERFORM THE FIVE MOMENTS OF HAND HYGIENE FOR ALL CANNULATION

PROCEDURES

The following diagram summarises the possible routes of bacterial entry
Infection may develop where the cannula enters the skin. Infection is indicated by
inflammation or the presence of pus and may progress to:
1. Cellulites in the surrounding tissues, with inflammation of the vein or

phlebitis
2. Bacteraemia (bloodstream infection), is the most serious infection
associated with IV therapy. This is frequently life threatening and involves
additional pain and suffering for patients and their families, as well as extra
treatment costs. Some common causes of cannula related infection are
Staph epidermidis, Pseudomonas, Enterobacter and MRSA.
BLOODBORNE PATHOGENS
In addition to the well known blood borne pathogens responsible for sero-
conversion following a sharps injury there is an additional 20 potential blood borne
pathogens that may be transmitted through sharps injury. Ref to the list below.
Hepatitis B,C,D Staphylococcus Aureus

HIV (AIDS) Streptococcus Pyrogene
Blastomycosis Syphilis
Ebola Fever Toxoplasmosis
Diptheria Leptospirosis
Herpes Simplex Brucellosis
Cryptococcosis Treponenma Pallidium
Dengue Fever Tuberculosis
Malaria Mycobacterium Marinum
Necrotising Faciitis Scrub Typhus
Source: International Health Care Workers Safety Centre, Charlottesville, VA

Prevention of Infection
Hand hygiene is key to minimizing /avoiding cross

contamination.
Effective hand hygiene is achieved by using a

combination of hand washing and alcohol hand gel
that kills both transit and normal skin flora. Hands
should be cleaned before and after palpating,
inserting, accessing, replacing or dressing an IV
cannula
(Centers for Disease Control and Prevention USA
2002 CDC Guidelines).
Aseptic Technique
Sterile equipment and an aseptic non-touch technique is used for the insertion and
management of peripheral IV cannula. Non sterile gloves should be used when
inserting a cannula or changing a dressing (CDC Guidelines, 2002). Gloves are
essential because of the significant health and safety risk to you, of infection from
blood-borne pathogens.
Where breaks in aseptic technique are likely to have occurred e.g. ambulance or
emergency situation, it is recommended that cannula be re-sited within 24 hours
(CDC Guidelines, 2002), in order to minimize the risk of infection to the patient.
Antisepsis
Chlorhexidine 2% aqueous has proved superior for skin antisepsis because its
effect is not reduced when in contact with blood and its antibacterial activity
persists for hours following application (Baranowski, 1993). When combined with
70% Isopropyl Alcohol (CDC Guidelines 2002) becomes a very effective skin
disinfectant.(Infect Control Hosp Epidemiol 2008)
Based on this evidence the skin antisepsis of choice at CDHB is an anti microbial
wipe containing 2% chlorhexidine and 70% alcohol. The importance of the cleaning
technique using friction to remove pathogens from skin and also prior to accessing
the access port is very important. (EPIC, 2004)

Occlusive Dressing
Transparent occlusive dressings have been widely accepted due to their advantages of
improved visualisation with early detection of complications, less catheter manipulation,
bathing possible without exogenous contamination, less frequent dressing changes and
increased patient comfort. The transparent occlusive dressings should last the life of the
cannula (i.e. 72 hours). However when the dressing becomes loose, damp or soiled it
should be replaced immediately. (CDC, 2002)
IV cannula dressings need to provide securement in a manner that prevents mechanical

phlebitis, infiltration or dislodgement. The CDHB preferred transparent dressing is the
Tegaderm™ IV Transparent Dressing 1633 which includes additional sterile tape to
secure the cannula thus maintaining the aseptic integrity of the hub and insertion site.
Site Care
Patients most at risk of peripheral IV site infection are those over 60 years of age, who
have had a previous IV phlebitis or site infection, are malnourished, or
immunocompromised. The most conclusive sign of infection is purulent discharge, but
this may not be evident until the device is removed. If the site appears inflamed or other
local and systemic signs of infection are present, such as inflammation, heat and pain,
remove and re-site the cannula and document findings in the patient‟s clinical notes.
In order to prevent infection, observation of the cannula site is required at the time of IV
drug administration or saline flush. The cannula should be flushed every 8 hours with
Normal Saline 0.9% 5ml when not in use. In addition, peripheral IV cannula should be
routinely replaced every 72 hours (CDC, 2002) to prevent phlebitis and infection. In the
event that you are asked to replace a cannula due to suspected phlebitis it is important
you recognise the signs and symptoms and have an understanding of phlebitis.(ref:
page 18)

THE EFFECTS OF IV SOLUTIONS AND MEDICATIONS
Knowledge of the pH and osmolality of solutions to be infused through peripheral

cannula is critical to best patient outcomes. Utilize the resources in your clinical area
to gain a better understanding of the IV fluids or medication to be administered.
Therapy Considerations
Nature of fluids - Osmolality - Overview

HYPOTONIC - below 240 milliosmols
H2O movement
Cell burst
ISOTONIC - similar to serum
No H2O movement
HYPERTONIC - higher than 340 milliosmols Cell intact
H2O movement Cell shrinks

Source: BD Clinical Education
Hypotonic solutions (less than 240mOsm/liter)
Hypertonic solutions (greater than 340mOsm/liter)

Phlebitis
Phlebitis is an acute inflammation of the vein directly related to the presence of an
intravenous cannula (Jackson, 1998). It is a frequent cause of pain and discomfort
to patients. Studies have shown that 27%-70% of patients receiving peripheral IV
therapy develop phlebitis that requires the removal of the cannula (Maki et al 1991)
there are three main causes of phlebitis:
1) Mechanical: Mechanical phlebitis is caused by either a difficult insertion and /

or poor securement causing movement of the cannula inside the vein resulting
in the vein becoming irritated, inflamed and oedematous. Mechanical phlebitis
can be reduced by adding an extension set (Hadaway, 1999; Millam, 2000;
CDC Guidelines 2002). This will reduce the amount of movement caused by
accessing the injection port at the insertion site.
2) Chemical: Chemical phlebitis occurs when the pH of a medication (eg
ciprofloxacin) or the osmoality of infusates (eg potassium) irritates the lining of
the smaller peripheral veins. This occurs because the flow rates are lower in the
periphery than those of larger central veins, therefore haemodilution of
solutions is less giving rise to the potential for intima damage. Therefore the
length of the medication or fluid regime will need to be assessed. For example,
length of therapy, method of delivery and dilution. Can the medication be further
diluted without compromising efficacy i.e. peak blood level. An alternative IV
device may need to be considered such as a central venous catheter (CVC) or
a peripherally inserted central line (PICC).
3) Bacterial: Bacterial phlebitis is caused through contaminated infusates,
equipment, inadequate hand hygiene or poor skin antisepsis resulting in
bacteria finding a point of entry at the insertion site. This occurs when
accessing the injection site or administering IV fluids past the expiry date.
Assessment
In order to detect phlebitis early, it is important to know the properties of the drug or
infusates you are administering and to be aware of patient factors that predispose
to phlebitis. Patient factors that increase risk of phlebitis include age, gender, (for
example elderly and women) presence of disease (such as diabetes) severe
debilitation, and level of activity (Campbell, 1998).
There is also some evidence to suggest that there is variable individual

susceptibility to phlebitis. Patients who develop phlebitis with the first cannula are
more likely to develop severe phlebitis with the second.(Maki et al 1991) In
addition, upper extremity cannula insertions have lower risk of phlebitis than lower
extremity and hand cannulation has a lower risk of phlebitis than the upper arm or
wrist.
Early signs of phlebitis present as erythaema and pain. It is important to remember

however, that by the time erythaema is seen, and inflammation has progressed
through all layers of the vein wall to the epidermis (Angeles, 1997). Pain may only
initially be felt on palpation and may not be a reliable indication of phlebitis
(Jackson, 1998). Induration and cording (hardness), of the vein on the other hand,
is considered highly indicative of phlebitis (Bohoney, 1993). If left unchecked,
phlebitis quickly advances and may result in thrombophlebitis and thrombosis and
complete occlusion of the vein or infection leading to septicaemia (Campbell, 1998;
Jackson, 1998).

The use of a phlebitis scale is recommended for promoting prompt identification of
problems, early intervention and reducing the incidence of phlebitis (Campbell,
1998).
The occurrence of phlebitis impacts not only on increased resource utilisation but
most importantly compromises the patient through pain, discomfort and limb
immobility affecting independence, reduced venous access and altered body
image (Jackson, 1998). Research also indicates that phlebitis lengthens hospital
stay (Campbell, 1998). For this reason it is essential that phlebitis is detected and
promptly managed.
0 No signs of phlebitis
OBSERVE CANNULA
+1 Possible 1st signs phlebitis

OBSERVE CANNULA
+2 Early phlebitis
RESITE CANNULA &
TREAT SITE
+3 Moderate phlebitis
RESITE CANNULA &
TREAT SITE. Take swab &
send to lab
+4 Advanced thrombophlebitis
RESITE CANNULA &
TREAT SITE. Take swab &
send to lab
Phlebitis Scale. Ref: Intravenous Nurses Society (2000). Infusion Nursing Standards of Practice.

Management
Researchers have established the benefit of using an extension set to reduce the
incidence of mechanical phlebitis (Hadaway, 1999; Millam, 2000; CDC Guidelines
2002). However, should phlebitis occur, complete the following:
Remove the cannula and cover with sterile dressing
Mark the area if reddened
Send swab and IV cannula, to laboratory if infection is suspected
Document event in patient‟s clinical notes
Rest and elevate the affected limb on pillow
Apply cold or warm compresses and hirudoid cream, according to patient
comfort
Post-infusion phlebitis can occur up to 96 hours post cannula removal therefore

continued assessment of the site post removal is recommended (Angeles, 1997).
Removal:
If you don’t need it, REMOVE it!
Research has shown that cannulae are frequently left unused is situ for two or
more consecutive days (Laderle, Parenti, Berskow, & Ellingson, 1992). This
poses a significant unnecessary risk to the patient. Leaving unused IV cannulae
in situ is avoidable if careful documentation, monitoring and prompt removal
practices are adhered to.
The risk of phlebitis from cannula placement increases as dwell time increases
(Fuller, 1998). Routine removal at 72 hours or at the first sign of phlebitis is
warranted (Briggs, 1998; CDC Guidelines, 2002).
Where adherence to aseptic technique has been compromised, i.e. when a
cannula is inserted during emergency situations, replace cannula as soon as
possible and after no longer than 48 hours (CDC Guidelines 2002).
Sharps Safety
The CDHB is sharps safety conscious and to protect staff
from potential needle stick injuries provides sharps safety
engineered devices to minimize needle stick injury. The IV cannula
used is the INTROCAN™ B-Braun safety cannula.
„Sharps must be handled with care at all times, disposed of safely immediately
following use, and not re-sheathed, bent , broken or manipulated by
hand’(Australia, New Zealand College of Anaesthetics (p 4 2005)

It is the responsibility of the person using the sharp to ensure it is safely disposed
of. Dispose of equipment safely into a sharps container at point of use. Ensure
sharps containers are conveniently placed, either on the trolley or on a stable
surface. If a needle stick injury should occur follow CDHB policy found in the
Infection Control Manual and follow prompts on the Staff Accident form.
In the event of a Needle Stick Injury

Wash wound under running water with soap
Cover with band aid
Have blood taken from you by a colleague trained in venepuncture. (go to
the Emergency department if out of hours)
Have blood taken from the source
Complete separate laboratory forms for self and the source
Send both blood specimens, lab forms and blood/serum/fluid report form to
Microbiology Canterbury Health Laboratories immediately
If you have been exposed to a known hepatitis B, C or HIV source contact
the Microbiologist on call immediately via the switchboard
Preparation
When the decision is made to cannulate a patient there are a number of factors
that need to be considered. Firstly you need to have a good understanding of the
indications for cannulation and goals of IV therapy. Appropriate decisions about
vein, site and cannula type can only be made on the basis of a thorough patient
assessment. Once these have been established patient teaching and preparation
is needed.
Assessment
Intravenous access devices should be selected depending on individual patient
needs. This requires comprehensive assessment of the patient, equipment,
therapy, environment and operator skill. The following questions should be
considered
Is the therapy short or long term?
Is it continuous or intermittent therapy?
What types of drugs or therapies are needed? (osmolality, pH, viscosity,
speed/volume, and compatibility with other therapy)
Does the patient have a history of lymphoedema, mastectomy, previous
access device insertion problems, surgical or radiotherapy intervention to
access site or fractures?
Does the patient have pre-existing co-morbidities such as coagulopathy,
sepsis or immunocompromised?
What is the allergy status of the patient? (local anaesthetic, skin antiseptic,
dressings)
Does the patient have good or poor venous access? (poor venous access
may be obvious due to poorly visible, bruised or thrombosed arm vessels)
What is the patient‟s preference?
What is the knowledge and skill of the person inserting the cannula?
(Hadaway, 1999; Dougherty, 2000)
In addition to these questions, read the clinical notes and consider any factors that
will influence effective cannulation e.g. extremes of age, steroid therapy, repeated
cannulation, history of phlebitis. You will need to identify and establish the patient‟s
previous experience of cannulation and history of a vasovagal response. Patients
with a positive history of vasovagal reactions are 7.5 times more likely to have a
reaction during venepuncture (Hadaway, 1999). Anxiety and pain can exacerbate
this (Hadaway, 1999). These patients may be good candidates for local
anaesthetics such as Amitop cream which takes approximately 20min to be
effective.
Practice point: Ensure an appropriate amount is applied to a suitable cannulation site

and remove the cream prior to cleaning the skin and inserting the cannula.
Teaching & Consent

The Code of Rights states that patients have the right to be fully informed and to
have informed consent. You will need to put your knowledge to good use when
explaining to the patient the procedure and reasons for needing an IV cannula,.
Your explanation should include:
The need for therapy
Medications, fluids to be infused
Probable duration of therapy
How the patient might feel
Possible related complications
A response to any questions or concerns
Consider the family/Whanau wishes
Patients should also be made aware of the risks associated with IV cannulation
[anxiety pain/discomfort, site infection, haematoma formation, arterial puncture and
nerve damage (Workman, 1999)] and any treatment alternatives. Obviously the
patient needs to give verbal consent for the procedure.
An adequate explanation and information for the patient should help reduce the
autonomic „fear‟ response and minimise venous vasoconstriction (which could
potentially hinder successful cannulation). Explaining the procedure and ongoing
care considerations will also encourage the patient‟s participation in monitoring for
possible complications and side effects.
Selection of Suitable a Vein

Aside from considerations of the purpose and duration of IV therapy, there are two
key determinants to vein selection 1) the vein itself and 2) the location or site.
Selection of a suitable vein is achieved by examining the veins of the patient‟s
forearm or hand. The tourniquet will need to be applied to do this. A suitable vein
for cannulation should feel round, firm, elastic, and engorged – not hard, bumpy or
flat. Inspect and palpate the vein for any potential problems. Avoid cannulating
veins that are:
Covered by bruising, inflammation, skin disease and/or otherwise injured
skin
Sclerosed or thrombosed (hard and/or tortuous) Distal to the site of an
infiltration or phlebitis or at flexion of joints

Practice Point: The importance of proper and adequate lighting when selecting
a vein for cannulation should not be overlooked.
Patients who have had several courses of IV therapy in recent times are likely to
have fewer suitable veins. Therefore, only a skilled clinician/nurse should perform
cannulation on patients with limited and/or „difficult „veins and those individuals that
are particularly anxious or distressed.
Selection of Suitable Site

There are some general guidelines to selection of an appropriate site, which
include:
For most adults, select veins in the non-dominant hand and arm
Always examine both arms before making a decision as to the best vein
available
Start at a distal site so that there are veins available for subsequent
cannulae to be placed proximal to the previous site.
If replacing an IV cannula, alternate the sites by cannulating above the
previous site avoiding tributaries of that vein use a vein that runs parallel to
the previous site or select a vein in the opposite arm.
Before performing cannulation at any site, palpate for arterial pulsation to
exclude / prevent inadvertent arterial cannulation. The brachial and ulnar
arteries can be quite shallow therefore this area should be avoided.
Veins in the antecubital fossa and above should not routinely be used for insertion
of peripheral cannulae. Use of the antecubital fossa site particularly limits the
patient‟s range of movement, is uncomfortable, interferes with blood sampling,
results in positional fluid infusion, increases the risk of mechanical phlebitis and
infiltration and may limit cannulation distally if infection occurs. (Midwives ref: p 39-
40) In addition to this, the following sites should be avoided:
Lower extremities – these should be cannulated only in emergency
situations by experienced physicians
Any areas of flexion
Hands and joints of arthritic patients or those using crutches or walkers,
whenever possible
Previous cannulation sites
Presence of a plaster, dressing, or operation sites
Areas of poor venous return or lymphoedema
Cannula Selection
The patient‟s IV therapy requirements should determine the most appropriate IV
device to be utilised (Hamilton, 2000). Ensure you have a selection of cannulae
available on the trolley to take to the bedside. The decision on cannula length /
size may change when examining the condition of the patient‟s veins.
As a general rule, the cannula selected should have the smallest diameter for the
purpose to allow blood flow around the cannula thereby lessening the risk of
phlebitis (Hadaway, 1999; Millam, 2000). The following two points are particularly
important when selecting the gauge and type of cannula:

SIZE of the vein. It needs to support the gauge and length of cannula to be
inserted.
Type of FLUID that is to be infused, e.g. blood. The cannula needs to be of
acceptable diameter to allow infusion of the product.
The following table is a general guide for INTROCAN Safety Cannula to assist
selection of an appropriate cannula.
Guide to INTROCAN™ IV Cannula

Gauge Length Uses Considerations
24 (yellow) 19mm Neonates Suitable for extremely small veins,
Paediatric, Elderly Slow flow rates.
Haematology / Onco
patients
22 (blue) 25mm Paediatric Easy to insert
Elderly Suitable for small or fragile veins,
Haematology & Onco short lengths. Can use for blood
patients products & all IV fluids &
medications
20 (pink) 25mm Adolescents, adults, Most commonly used for all IV
elderly fluids & medication & blood
products
18 (green) 32mm Adults Suitable for the administration of
viscous fluids (e.g. blood)or when
high flow is required
16 (grey) 32mm Adults/maternity Suitable for administration of large
patients quantities of IV fluid.
Rapid flow rate.
Painful at insertion, requires a
large vein
Equipment
Collect all the equipment needed for IV cannulation before going to the bedside or
take a pre-prepared cannulation trolley where practicable. This will ensure you:
Eliminate the need to leave the patient until the procedure is completed
Avoid breaks in asepsis
Promote patient confidence in your skills
Your equipment should include:

Gloves non-sterile
Chlorhexidine 2% & alcohol 70% wipe
Tegaderm IV transparent Dressing1633
Selected cannula x2 & local anesthetic optional
Tourniquet
Extension set/luer plug –primed with sodium chloride 0.9%
Posiflush 10mLpre-filled syringe sodium chloride 0.9%
Sterile guard & blue plastic backed sheet
Multi sorb gauze swab
Green ID labels x2

Parts of the INTROCAN ™ Safety Cannula
Familiarity with the components of a cannula is essential if you want to competently
perform cannulation. The following diagram names the components and describes
their function.
Air vent
Hub The proximal end
Colour coded indicator of the of the catheter
gauge of the catheter
Flashback chamber
Blood return will be seen here,
Stylet when vein is cannulated
The introducer needle that
punctures the skin but is
removed when the vein is
correctly cannulated Catheter
Flexible tube, which remains
in the vein
Safety Clip on Stylet

is activated at the point
of withdrawal
Insertion Procedure
The following describes the particular skills of cannulation and their rationale.
Preparing the Patient

In addition to providing adequate explanation and gaining consent for the
procedure, ensure:
The patient is warm and comfortable.
Restrictive clothing on the arm is removed.
Good lighting to promote easy visualisation
Initially choose your patients carefully, only attempting to cannulate patients

with good veins, when there is plenty of time, when you feel relaxed and
have backup available.
Don‟t feel discouraged if you are not successful at first. This skill takes time
to perfect and you will improve with practice.

Checking the Cannula
You need to examine the cannula for integrity of product prior to use. In particular,
check expiry date on the package. Be familiar with the manufacturers
recommendations i.e. don‟t attempt to re-insert the safety stylet. Discard if any
irregularities are evident (flared tip, plastic burrs on edges, dislodged needle
through cannula).
Applying the Tourniquet

The tourniquet is applied approx 15 cm above the selected site (Millam, 1992). It
should be pulled tight enough to cause engorgement of the lower capillaries and
veins, without cutting off arterial flow. If the skin becomes mottled or blue or you
can‟t feel a pulse below the tourniquet (or if the patient complains of discomfort)
then the tourniquet is too tight.
Single use disposable tourniquets are recommended (Intravenous Nurses Society,

2000). The same tourniquet used on multiple patients may lead to cross
contamination. Re-useable tourniquets should be cleaned after each use.
Be aware that tourniquets can also be a source of latex contact, so assess the
patient‟s allergy status prior to use.
Preparing the Site

Preparing the site involves skin antisepsis and hair removal. Some authors
recommend that antimicrobial solution should be applied to the site in a circular
motion, starting at the intended insertion point and working outward, using firm
friction (Baranowski, 1993; EPIC, 2004).
Although the surface area for prepping depends on the size of the extremity, in
adult patients an area of approximately 50 – 100mm in diameter is usual. Never
blot excess solution at the insertion site. Let the solution air dry completely. Do not
re-palpate the site once skin antisepsis is complete, unless you are wearing sterile
gloves (CDC Guidelines, 2002).
Hair on the skin that prevents adhesion of the transparent dressing will require
removal. Hair removal is best achieved with clippers. 3M clippers have been
supplied to all clinical areas. These come with detachable single-use heads.
Shaving is not recommended it can cause micro abrasions of the skin and
increase the potential for infection (Intravenous Nurses Society, 2000).
Methods of Vein Dilation

Once the tourniquet is in place promote vein dilation. Vein dilation can be
achieved in a number of ways. You may have to do one or a combination of the
following:
1) Ask the patient to open and close their fist – use a soft ball or washcloth for the
patient to squeeze if making a fist is difficult.
2) Place the selected arm in a position below the level of the heart to help engorge
the veins and increase visibility then tighten tourniquet.
3) Gently tap the area to release histamine beneath the skin and cause
vasodilation.
4) Apply warmth to the area 5 – 10 minutes beforehand to dilate veins.

NB if the patient is cold, applying heat to the area for cannulation will ensure a
successful procedure and patient satisfaction.
Following these measures the vein should feel elastic and have rebound resiliency
i.e. when you press and release the vein, it should spring back to a rounded, filled
state. Achieving this may take some time or may not occur at all and re-selection of
a vein may need to take place.
Holding the Device: Becoming comfortable when holding the cannula, may
take time, however it is important for successful cannulation.
Hold the cannula horizontal with hand on top of the device. This way the
proper entry angle is assured and allows maximum flexibility of wrist when
inserting the device.
Fingers should be on the flashback chamber – not on the colour portion of
hub. This is to ensure you are ready to thread the cannula into the vein.
(You can‟t do this if you have hold of it).
Never hold cannula like a “Dart”. Cannulation is distinctly different from an
IM injection. Using the cannula like a „dart‟ will not only cause discomfort but
is likely to result in transecting the vein.
Immobilising the Vein

Vein stabilisation is performed with the non-dominant hand and maintained until
the cannula has been threaded into the vein. Stretching the skin distal to the vein
will maintain the vein in a taut, distended, stable position and reduce the tendency
to roll. This can be done by gently pulling the skin in a downward motion.
Superficial veins have the greatest tendency to roll. Hand veins are generally
easier to immobilise and can be easier to cannulate because they‟re usually
surrounded with less fatty tissue. Using a good technique to immobilise the vein is
critical to success.
Approaching the Vein

There are several ways an IV cannula can be
inserted. Regardless of which method is used, the
cannulae should enter the skin at such an angle that
the needle punctures the vein wall and enters the
lumen without piercing the opposite wall.
The most common methods are:

Approaching the vein from the top
Approaching the vein from the side
Approaching the vein at a bifurcation
Practice Point: Always keep your fingers behind the point of the stylet at all times

For further information read the article:
 Starting IV’s: How to develop you venipuncture expertise by D.

Millam (1992) (for full details see References).
Inserting the Cannula:

The stylet is inserted bevel up at 10 - 45° angle (Briggs, 1998) depending on the
depth of the vessel. The stylet is inserted bevel up to minimise discomfort and
reduce the risk of puncturing the back wall of vein. The INTROCAN ™ Safety
Cannula has a push off tab and when uppermost this confirms the bevel is in the
correct position for insertion
1. The skin is pierced using a smooth firm action. Blood will appear in the hub
of the cannula as soon as the vein is entered.
The appearance of blood in the hub is usually a sign of successful
cannulation.
Blood may also enter the hub if the vein has been transected i.e. punctured
through. If this occurs, you will not be able to advance the cannula (see next step)
and a haematoma will usually immediately appear.
Advancing the Cannula
2. Once blood is seen in the hub, advance the device slightly and then „level
off‟ the entry angle by lowering the cannula and stylet level with the patient‟s
skin. This ensures that the cannula is well within the lumen of the vein and
reduces the chance of creating a false lumen between the vein wall layers.
Still retracting the skin, gently push the hub to slide the cannula off the stylet
and advance completely into the lumen of the vein.
Release the Tourniquet!

Releasing the tourniquet at this point ensures that when you proceed to
removing the stylet, less blood will ooze from the cannula.

Remove the Stylet
3. In addition apply digital pressure beyond the cannula tip to prevent blood
spillage. Stabilize the hub with the non-cannulating hand (see finger position
above) and withdraw the needle/stylet.
Discard the stylet immediately into the sharps container.
An acronym to help reinforce the crucial steps in the cannulation procedure is:
BLATS
B lood return, advance cannula slightly
L evel off
A dvance into vein using push off tab
T ourniquet removal
S tylet removal
Attach Extension Set

With the hub still stabilised, attach the primed SmartSite extension set with
injection port (luer plug). An extension set is recommended to reduce mechanical
phlebitis (Hadaway, 1999; Millam, 2000;CDC Guidelines 2002). Flush the cannula
to ensure patency. It should flush easily. If any immediate swelling is observed the
cannula should be removed. If stinging, or significant patient discomfort occurs,
reassess the site, ease of insertion and consider the need for removal.

SECUREMENT & DRESSINGS
There is an expectation that the device will achieve a 72 hour dwell time.
Therefore it is essential that an appropriate dressing and securement technique is
used.
Use the recommended TEGADERM™ IV Cannula dressing which includes sterile

tape to secure the cannula. The first tape is placed over the cannula hub, the
dressing applied and the second tape is applied just below where the extension set
and hub connect.
Do not completely obscure the entry site with tape, otherwise monitoring for
phlebitis may become difficult. Excessive manipulation should be avoided to
prevent trauma at the site and inadvertent dislodgement (Rosenthal, 2003).
Inadequate securing of the cannula will allow catheter movement and provide
access for bacteria, potentially leading to phlebitis, thrombosis and infiltration
(Hadaway, 1999).
A transparent dressing is applied over the sterile tape. Apply the transparent
dressing up to where the cannula hub and extension set met. If the connection with
extension set is taped over it does not allow for disconnection or changing if
necessary. Press the dressing into place to seal the dressing firmly to the patient‟s
skin.
Practice Point: Apply the dressing directly to the site without stretching, as
this may cause irritation to the patient‟s skin.
DOCUMENTATION
Document accurately as follows:
1) At the site –the 1st GREEN ID label complete with the date, time, inserters
name, signature and expiry then attach to the side of the dressing so as not
to obscure the insertion site .
2) Patient Clinical Record – the 2nd GREEN ID label completed as above is
placed in the patients clinical notes. In addition, record any variances of
procedure along with patient teaching / education that was provided
including explanation of risks and consent to procedure. It is important to
note the patients response, any adverse effects and action taken (see
potential complications)
For more information read the article:

 Where did this patients IV therapy go awry by K Rosenthal
(2004) (for full details see References)

THE COMPLETED IV CANNULA DRESSING

Trouble Shooting
Problem Practice tips
If the patient is cold, hypotensive or nervous and experiencing vasomotor
Difficulty
changes, you can expect to spend a little extra time dilating the vein
dilating the
before cannulation. Apply the tourniquet and assess the veins. If they are
vein
slow to fill, try the following tips:
Position the arm below heart level or hang the arm down to
encourage capillary filling.
Gently rub or stroke the arm to warm the skin.
Cover the arm with a warm towel for 5-10 minutes to trigger
vasodilation.
Get patient to open and close hand to aid venous dilation
Apply heat to area for 5-10 minutes
If blood backflow stops when you remove the stylet, the cannula may
Puncturing the
have passed through the opposite wall. If this is suspected, you may still
Vein
be able to complete a successful cannulation;
Without removing the tourniquet, retract the cannula slightly until

blood flashback appears again, indicating that you‟ve pulled the tip
back into the lumen of the vein.
„Level off‟ the angle and advance the cannula into the vein and
promptly remove the tourniquet.
Never try and reinsert the stylet
Inappropriate insertion angle (too steep or not steep enough) can cause
Failure to
the cannula to ride on top of or below the vein. If the cannula won‟t move
Insert the
freely, it usually means that it has been inserted too deep, and it is
Cannula
embedded in fascia or muscle. The patient may also complain of severe
discomfort. Action:
Adjust the angle of entry.
If still not successful, remove and reassess.
Repeat attempt no more than two times, before seeking assistance
from a more experience clinician
This can occur if you have hit a valve or if you have failed to adequately
Inability to
anchor the surrounding skin. Try:
Advance the
Cannula Attaching a saline filled syringe and gently flushing. If no resistance
is felt, advance the cannula, while flushing, as this may open the
valve allowing the catheter to move through.
Any twisting of the vein or continued resistance, abandon the
cannulation attempt and re-site elsewhere.

Problem Practice tips
Patient with fragile skin are at increased risk of tissue trauma and failure
Fragile skin
to cannulate.
Use the smallest cannula possible e.g. 24g or 22 g
Encourage vein dilation with warmth.
Apply minimal tourniquet pressure or substitute for a blood
pressure cuff inflated just enough to distend veins
Use decreased angle of entry
Venous spasm is a sudden involuntary contraction of the vein into which
Venous Spasm
a cannula or solution is being placed (3M, 1999) and may result from
traumatic cannulation. It is characterised by sharp, cramping, pain above
the insertion site and skin blanching.
A warm compress can be applied to the site (3M, 1999;
Springhouse, 1999).
If unrelieved, re-site the IV cannula.

POTENTIAL COMPLICATIONS
All complications should be clearly documented in the patient‟s clinical records, including
patient response and actions taken. If the nature or complication is serious then an event
form should be completed
Complication Action
Infiltration Remove the cannula

Establish whether cannula needs
Infiltration can occur through using a
to be re-sited
large cannula in small vein or is the result
of a cannula puncturing the vein wall Re-evaluate size of cannula
causing the leakage of infusate into the Re-site new cannula
subcutaneous tissue and swelling at the Where prescribed, recommence
site. infusion
The surrounding skin is usually cool to
the touch, there may be evidence of
blanching and fluid may leak at the entry
site.
Arterial Cannulation Stop cannulating immediately.
Remove the cannula and apply
Arterial cannulation is identified by the
pressure for at least 5 minutes or
appearance of bright red pulsating blood
until no bleeding occurs / visible
in the hub of the cannula (when the
haematoma formation.
tourniquet and other proximal occlusions
are absent). Document incident and actions in
Blanching, pain or diminished pulse may clinical notes
be noted distal to the cannula.
Normal Blood Flow Smaller Cannula Large Cannula

Reduces Blood Flow No Blood Flow Around
Around Cannula but still Cannula
allows flow around (Blood detours around
cannula obstruction)

Complication Action
Ways to prevent this happening include:
Haematoma
Correct angle of insertion and levelling off
Haematoma is an interstitial swelling once in the vein lumen
at / near insertion site caused by Choosing best possible vein, with good
bleeding into the tissues. blood volume
Possible causes include: Using a smallest cannula needed
Insertion angle too deep, or not Try to avoid small capillaries that lie over the
steep enough vein
Failure to „level off‟ after If haematoma does occur, usually the cannulation
entering the vein has to be abandoned. Occasionally the cannulation
Fragile veins due to age, attempt is successful. However the resultant
medical condition, steroids use haematoma significantly reduces the dwell time of
etc. the cannula and increases the risk of phlebitis and
infection.
Vein has been punctured
Capillaries have been damaged
at point of insertion
Nerve Injury Immediately remove the cannula and inform
the doctor
Nerve injury should be suspected if
Explain possible cause and actions to patient
the patient complaints of pain, „pins
and needles‟ / or sharp sensation Provide reassurance as appropriate
going down to the fingertips. Document incident in clinical notes
Where vasovagal reaction/ syncope known,

Vasovagal Reaction (Syncope)
prevention strategies include:
A vasovagal reaction is characterised Cannulation by skilled practitioner only
by light-headedness, blurred vision,
Apply topical local anaesthesia prior to
sweating, nausea & tinnitus. During
insertion
cannulation this reaction is usually
caused by blood or injury phobia. Have the patient in the supine position
Pain and anxiety in turn result in In event of vasovagal reaction:
inappropriate triggering of the Stop the cannulation (or complete
autonomic response that causes procedure promptly)
vasodilation and bradycardia (Wright Call for help lie the patient supine
& Arnolda, 2003). In the sensitive
Administer oxygen
individual it may progress to syncope,
although this is extremely rare If the patient appears to „fit‟, prevent injury
Deacon & Abramowitz, 2006). Simple If reaction is pronounced consider:
vasovagal reaction will usually Administration of atropine or alpha-agonist
respond to stopping the stimulus (as prescribed)
(Kinsella & Tuckey, 2001). IV fluid bolus where hypovolemia suspected
(as prescribed)

ADDITIONAL INFORMATION:
The most common mechanical complications of intravenous therapy administered via a
peripheral vein are thrombophlebitis and infiltration with extravasation of the infusate.
(Goodinson 1990)
Infiltration.
Infiltration is the leaking of non- vesicant drugs or infusates from the cannulated vein into
the surrounding tissue causing inflammation, pain and oedema. Causes of infiltration are,
tight tape, bandage or clothing above the cannulation site, cannula too large for the vein, the
opposite wall of the vein has been transected. Non vesicant drugs or infusates do not cause
tissue necrosis.
Extravasation.
Extravasation refers to the leaking or infiltration of a vesicant drug or solution into the
surrounding subcutaneous tissues causing tissue necrosis and sloughing (Goodinson 1990)
This can occur as the result of vein damage during cannulation, infusing the drug or solution
too quickly, using a peripheral cannula that is too large for the vein, using limbs with
compromised circulation or sites that have been exposed to radiation. In addition, tight
clothing or bandages above the cannula site can also contribute to extravasation.
A variety of non cytotoxic fluids and drugs which are of different osmolality or pH from the
tissues or have a vaso constrictive action are also capable of causing severe tissue damage
if extravasated. These include:
Potassium Chloride (>40mmol/l) Amphotericin

Digoxin Calcium Chloride
Phenergan Calcium Gluconate
Diazepam Alcohol
Tetracyclines Phenytoin
Cefotaxime Sodium Bicarbonate (>5%)
Ganciclovir Mannitol
Sodium thiopental Vancomycin
Aciclovir TPN
Aminophyllins Contrast dye
(http://www.extravasation.org.uk/home.html)
Management of Extravasation:
Stop administration immediately and notify medical staff
Do not flush cannula
Try to withdraw any solution by pulling back on syringe
Remove cannula apply gauze over area. Do not use occlusive or tight dressings
Mark area with a pen
Moist cold compresses may be helpful or cover with ice pack for 24hrs
Document incident in clinical notes and complete the Quality Improvement Event
Reporting Form
Refer to Pharmacist for appropriate antidotes
Prevention is the best treatment

EXTRAVASATION ASSESSMENT TOOL
Skin Colour Normal Pink Red Blanched area Blackened

surrounded by
red
Skin integrity Unbroken Blistered Superficial Tissue loss Tissue loss &
exposed
Consider Skin loss Exposed
bone/muscle with
plastics subcutaneous
necrosis
referral tissue
Skin Normal Warm Hot
temperature
Oedema Absent Non- Pitting

pitting
Limb Mobility Full Slightly Very Immobile

limited limited
Pain Grade using a scale of 1-10; where 0 = no pain and 10 = worse pain
Fever Normal Elevated
Follow up Guidelines in the event of an extravasation
Follow up should occur on day 2 (ie, day after extravasation) 3,5 and 7
Follow up on days 4 and 6 can be via a telephone call(outpatients) if
appropriate
Frequency of follow up after day 7 will depend on assessment of the site but
injury will need to be assessed weekly for the first four weeks Ref: 2188
Oncology /Haematology CDHB Extravasation Document 2009

Additional Information:
Women in labour:
Midwives cannulate in a wide variety of situations including emergencies, where women are
in labour.
When pregnant women bleed, they loose large volumes of blood very quickly. Blood flow
over the placental site is approximately 500mls per minute. When the uterus does not
contract efficiently following placental separation, a woman is at risk of losing her entire
blood volume in less than 10 minutes. This is categorised as a medical emergency.
Whilst the veins of choice for midwives are usually the dorsum of the hand or lower forearm,
in an emergency situation the large veins of the anti cubital fossa are the veins of choice.
These veins provide easy access, the ability to accommodate 16 or 14 gauge cannula and
allow for high flow rapid infusions of IV fluids, blood and blood products. These veins are
also commonly used by the Emergency Department.
Intra-arterial cannulation: Although rare, the most risky area is the medial side of the
antecubital fossa where the brachial artery is quite shallow. It lies close to the median
cubital vein.
Practice Point: To provide patient comfort, it is strongly recommended that a local

anaesthetic of lignocaine 1% is administered as a small sub-dermal bleb at the chosen site
for cannulation prior to inserting an 18g -16g cannula.

Taking a Blood Sample from a Peripheral IV Cannula:
The most accurate method for blood sampling is by using venepuncture. However whilst
not recommended the cannula may be used to withdraw blood for the purpose of blood
sampling.
Practice Point:
If a blood sample is required at the time of cannula insertion connect a blue tip male adapter
vacutainer to the SmartSite luer plug and insert blood tubes in correct order of draw.(Ref to
images below)
The CDHB policy states that non sterile gloves are to be worn during cannulation and blood
sampling for personal protection against blood borne pathogens.
Child Health:
Please refer to local IV cannulation policy in Paediatrics Guidelines.

Cannulation of Renal Patients
A Renal patient is classed as any patient under the care of the „Nephrology Department‟ for
chronic renal disease or end stage renal disease.
The following guidelines should be adhered to when performing Cannulation (or

venepuncture) on renal patients.
Avoid puncturing the cephalic vein of either arm

Access the patient‟s DOMINANT arm if at all possible (an AVF will always be formed
in the non dominant arm when possible).
The best site for Cannulation is the back of the patient‟s hand.
Where Cannulation of the cephalic veins cannot be avoided refer to Nephrologist or
Nephrology Registrar BEFORE proceeding
IMPORTANT PRACTICE POINT:

Preventing damage to the vessel that may subsequently be required for AVF formation is
key to patient treatment outcomes.

References:
3M Skin Health Programme – IV Complications. (1999). (Retrieved June 2002).
www.3m.com/us/healthcare/professionals/skinhealth/pdfs/iv_complications.pdf
Angeles, T. (1997). How to prevent phlebitis, Nursing97, January, 26
Australia, New Zealand College of Anaesthetists. (2005). Guidelines on infection control in
anaesthesia. ANZCA. Retrieved February 13 2006, from
http://www.anzca.edu.au/pdfdocs/PS28_05.PDF
Bohony, J. (1993). Common IV complications and what to do about them. American Journal of
Nursing, 93, (10), 45-49.
Campbell, L. (1998). IV-related phlebitis, complications and length of hospital stay: 1. British Journal
of Nursing, 7, (21), 1304-1312.
Campbell, T. & Lunn, D. (1997). Intravenous Therapy: current practice and nursing concerns. British
Journal of Nursing, 6(21), 1218 – 1228.
Centres for Disease Control. (2002). Guidelines for the prevention of intravascular catheter-related
infections. Morbidity & Mortality Weekly Report, 51(RR10), 1-32.
Deacon, B. & Abramowitz, J. (2006). Fear of needles and vasovagal reactions among phlebotomy
patients. Journal of Anxiety Disorders, retrieved from www.sciencedirect.com
Dougherty, L. (1996). Intravenous Cannulation. Nursing Standard, 11(2) 47-54.
Dugger, B. (1997). Intravenous nursing competency: why is it important. Journal of Intravenous
Nursing, 20(6), 287-297.
EPIC – National Evidence Based Guidelines for preventing hospital-acquired infections
associated with the use of central venous catheters – Part A
www.epic.tvu.ac.uk/PDFFiles/CVC%20Tech%20Report%20part%20A.pdf
Fuller, A. (1998). The management of peripheral IV lines. Professional Nurse, 13, (10), 675- 678.
Goodinson,S.M.(1990) The risk of IV therapy. Professional Nurse 5(5): 235-238
Hadaway, L. (1999). Vascular access devices: meeting patients‟ needs. MEDSURG Nursing, 8(5),
296-303.
Hamilton, H. C. (2000). Selecting the correct intravenous device; nursing assessment. British
Journal of Nursing 9(15), 968 – 978.
Intravenous Nurses Society. (2000). Infusion Nursing Standards of Practice. Journal of Intravenous
Nursing, 23(6S), S1-S88.
Jackson, A. (1998). A battle in vein: infusion phlebitis. Nursing Times, 94(4), 68, 71
Jagger, J., Perry, J. ,Safer needles: Not optional. Nursing2002. 32(10):p.20.
Kinsella, S. M. & Tuckey, J. P. (2001). Perioperative bradycardia and asystole: relationship to
vasovagal syncope and the Bezold-Jarisch reflex. British Journal of Anaesthesia,
86(6)859-868.
Lundgren, A. & Wahren, L. K. (1999). Effect of education on evidence-based care and handling of
peripheral intravenous lines. Journal of Clinical Nursing, 8, 577-585.(2005)
Maki,D.G.,Ringer,M., (1991) Risk Factors for Infusion-related Phlebitis with Small Peripheral Venous
Catheters. Annals of Internal medicine Vol1.14;No.10,15 May
Millam, D. A. (2000). On the road to successful IV starts. Nursing 2000. 30(4) 34 – 48.
Robert, J., Fridkin, S. K., Blumber, H. M., Anderson, B., White, N., Ray, S. M., Chan, J. & Jarvis, W.
R. (2000) The influence of the composition of the nursing staff on primary blood stream
infection rates in a surgical intensive care. Infection Control and Hospital Epidemiology,
21(1), 12-17.

Rosenthal, K. (2003). Pin-pointing intravascular device infections. Nursing Management, 34(6), 35-
43.
Rosenthal, K. (2004). Where did this patients IV therapy go awry. Nursing2004, 34(5), 56-57.
Small,H.Adams,D,Casey,A.Crosby,C.Lambert,P(2008.) Efficacy of adding 2% Chlorhexidine to
70% isopropyl alcohol for skin disinfection prior to peripheral venous cannulation.
Infection Control and Hospital Epidemiology. October,Vol.29,No.10
Stranz, M. (2002). Adjusting pH and osmolarity levels to fit standards and practices. JVAD. Fall:
12-17.
Tarantola,A., Abiteboul, D., Rachlinec,A (2006.) Infection risks following accidental exposure to
blood or body fluid in health care workers: A review of pathogens transmitted in
published cases. Am J Infect Control;34:367-75.
UK National Extravasation Information Service. (http://www,extravasation.org.uk/home html
Vaghadia, H., al Ahdal, O. A., & Nevin, K. (1997). EMLA patch for intravenous cannulation in adult
surgical outpatients. Canadian Journal of Anaesthesia. 44,(8), Aug: 798 – 802.
Volume 12 CDHB Fluid & Medication Management Policy
Weinstein, S. M. (2000). Certification and credentialing to define competency-based practice.

Journal of Intravenous Nursing, 23(1), 21-28.
Wilkinson, R. (1996). Nurses‟ concerns about IV therapy and devices. Nursing Standard, 10(35), 35-
37.
Workman, B. (1999). Peripheral intravenous therapy management.
Nursing Standed.14(4):53-60
Wright, J. J. & Arnolda, L. F. (2003). Dizziness and loss of consciousness: cardiovascular causes.
Australian Family Physician, 32(4), 207-210.
Additional References for use of extension sets:

RNAO Registered Nurses Association of Ontario 2005
Hadaway L.(2010) Infusion Therapy
Leeds teaching Hospital NHS Trust Peripheral cannulation Guidelines
(2008)7,(6.5.11)
Gloucester Hospital NHS (2012) p7

Cantebury IV Line

Uploaded by

Copyright:

Available Formats

Cantebury IV Line

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Cantebury IV Line

Uploaded by

Copyright:

Available Formats

PERIPHERAL INTRAVENOUS CANNULATION

SELF LEARNING PACKAGE

Updated: September 2013

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 1

Dr Heather Byrne PDU Nurse Manager

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 2

Anatomy & Physiology ..................................................................................... 7

Infection Control ............................................................................................. 13

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 3

Potential Complications ................................................................................. 35

Additional Information .................................................................................... 37

References ............................................................................................... 41-43

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 4

With increased scope of practice comes increased professional accountability

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 5

1. Complete the Level one IV Therapy competency

Self Learning Package

Enrolled Nurses Please Note:

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 6

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 7

1) The outermost layer is the tunica externa or adventitia, and is composed of

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 8

Differences between Arteries & Veins

More muscle for their diameter, Less muscle therefore tend to

ALERT: While an artery can inadvertently be cannulated, it is uncommon. Having a

Vein Location & Characteristics

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 9

Location/ Characteristics Clinical Considerations

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 10

Location/ Characteristics Clinical Considerations

6) Median Vein Accommodates 24-20g cannula

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 11

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 12

Risks of infection associated with cannulation can be

Ports of bacterial entry, in order of significance are:

PERFORM THE FIVE MOMENTS OF HAND HYGIENE FOR ALL CANNULATION

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 13

1. Cellulites in the surrounding tissues, with inflammation of the vein or

Hepatitis B,C,D Staphylococcus Aureus

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 14

Hand hygiene is key to minimizing /avoiding cross

Effective hand hygiene is achieved by using a

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 15

IV cannula dressings need to provide securement in a manner that prevents mechanical

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 16

Knowledge of the pH and osmolality of solutions to be infused through peripheral

Nature of fluids - Osmolality - Overview

H2O movement Cell shrinks

Hypotonic solutions (less than 240mOsm/liter)

Hypertonic solutions (greater than 340mOsm/liter)

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 17

1) Mechanical: Mechanical phlebitis is caused by either a difficult insertion and /

There is also some evidence to suggest that there is variable individual

Early signs of phlebitis present as erythaema and pain. It is important to remember

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 18

+1 Possible 1st signs phlebitis

Canterbury District Health Board Intravenous Cannulation Handbook 2010 pg. 19

Post-infusion phlebitis can occur up to 96 hours post cannula removal therefore

If you don’t need it, REMOVE it!